13 October, 2026 | Tuesday | News

Agreement is expected to grant Theramex exclusive rights to CEVIRA® in Europe, Australia, New Zealand and Turkey, while Asieris retains rights for the rest of the world. The deal includes 15 million US d...

15 October, 2026 | Thursday | News

Accelerates research and development by enabling AI-augmented workflows and automated lab-in-the-loop cycles, already a new and fast-growing source of demand for Waters' instruments and consumables Leverages...

15 October, 2026 | Thursday | News

Wuhan Hiteck Biological Pharma Co., Ltd.  announced that it has entered into an exclusive license agreement (the "License Agreement") with Visara, Inc. ("Visara"), a majority-owned ophthalmology subsidiary...

14 October, 2026 | Wednesday | News

  The new 360biolabs facility in North Ryde is strategically located within one of Sydney’s vibrant science and medtech hubs, Macquarie Park Innovation District alongside a growing community of inno...

15 October, 2026 | Thursday | News

- Rona Therapeutics announced it has granted Roche an exclusive worldwide license for Rona's investigational RNAi candidate targeting activin receptor-like kinase 7 (ALK7) utilizing the company's proprietary ex...

12 October, 2026 | Monday | News

Shenzhen Ninenovo Technology Limited, the parent company of RingConn, announced that its Smart Ring has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for non-invasive blood oxygen (...

15 October, 2026 | Thursday | News

NueCell Bio, a translational development partner that helps advance cell therapies from scientific discovery to GMP readiness, announced it has joined the Industry Resource Partnership (IRP) Program of the Cali...